# A Study to Evaluate Ertapenem Versus It's Comparator in the Treatment of Complicated Intra-abdominal Infections in Adults (0826-050)(COMPLETED)

> **NCT00157898** · PHASE4 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 134 (actual)

## Conditions studied

- Complicated Intra-abdominal Infection

## Interventions

- **DRUG:** MK0826; ertapenem sodium
- **DRUG:** Comparator: ceftriaxone + metronidazole

## Key facts

- **NCT ID:** NCT00157898
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-01
- **Primary completion:** 2004-08
- **Final completion:** 2004-09
- **Target enrollment:** 134 (ACTUAL)
- **Last updated:** 2017-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00157898

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00157898, "A Study to Evaluate Ertapenem Versus It's Comparator in the Treatment of Complicated Intra-abdominal Infections in Adults (0826-050)(COMPLETED)". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT00157898. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*